10
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 261-267 | Published online: 29 Sep 2008

LITERATURE ALERTS

  • A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells. EL- KAREH, A. W., and SECOMB, T. W. Neoplasia, 2000, 2, 325–338.
  • A TEM and EPR investigation of the competitive binding of uranyl ions to starburst dendrimers and liposomes: potential use of dendrimers as uranyl ion sponges. 0 TTAVIANI, M. F., FAVUZZA, P., BIGAZZ I, M., TURRO, N. J., JocKuscH, S., and TOMALIA, D. A. Langmuir, 2000, 19, 7368–7372.
  • Administration of a modified chemotherapeutic regimen containing vincristine, liposomal doxorubicin and dexamethasone to multiple myeloma patients: preliminary data. TS IARA, S. N., KAFS ALI, E., CHRIS TOU, L., PANTELI, A., PRITS IVELS, N., and BOURANTAS, K. L. European Journal of Haematology, 2000, 65, 118–122.
  • An investigation of some of the factors influencing the jet nebulisation of liposomes. BRIDGES, P. A., and TAYLOR, K. M. G. International Journal of Pharmaceutics, 2000, 204, 69–79.
  • Apolipoproteinphospholipid vesicles, and cyclodextrins as potential anti-atheroscleroticdrugs: delivery, pharmacokinetics, and efficacy. DASS, C. R., and JEssuP, W. Drug Delivery, 2000, 7, 161–182.
  • Assessment of microencapsulated formulations for improved residual activity of Bacillus thuringiensis. TAMEZ -GUERRA, P., McGumE, M. R., BEHLE, R. W SHASHA, B. S., and WONG, L. J. G. Journal of Economic Entomology, 2000, 93, 219–225.
  • Attenuation of nephrotoxicity by a novel lipid nanosphere (NS- 718) incorporating ampho-tericin B. HOSSA IN, M. A., MAESAK I, S RAZZAQUE, M. S TOMONO, K., TAGUCHI, T., and KOHNO, S. Journal of Antimicrobial Chemotherapy, 2000, 46, 263–268.
  • BAX-dependent transport of cytochrome c reconstituted in pure liposomes. SAITO, M., KORSMEYER, S. J., and SCHLES INGER, P. H. Nature Cell Biology, 2000, 2, 553–555.
  • Beneficial effects of prostaglandin E-1 incorporated in lipid microspheres on liver injury and regeneration after 90% partial hepatectomy in rats. ANDO, K., MIYAZAKI, M., SHIMIZU, H., OKUNO, A., and NAKAJIMA, N. European Surgical Research, 2000, 32, 155–161.
  • Biodegradable pH-sensitive surfactants (BPS) in liposome-mediated nucleic acid cellular uptake and distribution. LIANG, E., ROSENBLATT, M. N., AJETANI, P. S., and HUGHES, J. A. European Journal of Pharmaceutical Sciences, 2000, 11, 199–205.
  • Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model. SUNG, M. W., LEE, S. G., YOON, S. J., LEE, H. J., HEO, D. S., KIM, K. H., Kou, T. Y., Cuoi, S. H., PARK, S. W., Koo, J. W., and KWON, T. Y. Anticancer Research, 2000, 20, 1653–1656.
  • Cationic liposomes as gene transfer vectors: barriers to successful application in gene therapy. SIMOES, S., P IRFS, P., DUZGUNFS, N., and DE LIMA, M. C. P. Current Opinion in Molecular Therapeutics, 1999, 1, 147–157.
  • Characterization of ovalbumin-containing polyurethane microcapsules with different struc-tures. HONG, K., and PARK, S. Polymer Testing, 2000, 8GA, 351JXJ9, 975–984.
  • Chitosan microspheres in PLG films as devices for cytarabine release. BLANCO, M. D., GOMEZ, C0 LMO, R., MUNIZ, E., and TEIJoN, J. M. International Journal of Pharmaceutics, 2000, 202,29–39.
  • Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. DAS, G. S., RAO, G. H. R., WILSON, R. F., and C HANDY, T. Drug Delivery, 2000, 7, 129–138.
  • Compaction of DNA in an anionic micelle environment followed by assembly into phos-phatidylcholine liposomes. MURPHY, E. A., WARING, A. J., HAYNES, S. M., and LONGMUIR, K. J. Nucleic Acids Research, 2000, 28, 2986–2992.
  • Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxor-ubicin, and beta-glucuronidase-activated prodrug (HLVIR 1826). WOESSNER, R., AN, Z. L., LI, X. M., HOFFMAN, R. M., Doc, R., and BIT ONT I, A. Anticancer Research, 2000, 20, 2289–2296.
  • Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. SANT INI, B., ANT0NELLI, M., BAT T IS T INI, A., BERTAS I, S., COLLURA, M., ESPOSITO, I., DI FEBBRARO, L., FERRARI, R., FERRERO, L., LAPICHINO, L., LUCID', V., MANCA, A., P ISCONTI, C. L., Pisi, G., RAIA, V., ROMANO, L., ROSATI, P., GRAZ IOLI, I., and MELZ I, G. Digestive and Liver Disease, 2000, 32, 406–411.
  • Controlled release of drugs from injectable in situ formed biodegradable PLGA micro-spheres: effect of various formulation variables. JAIN, R. A., RHODES, C. T., RAILKAR, A. M., MALICK, A. W., and SHAH, N. H. European Journal of Pharmaceutics and Biopharmaceutics, 2000, 50, 257–262.
  • Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. STENEKES, R. J. H., LOEBIS, A. E., FERNANDES, C. M., CROMMELIN, D. J. A., and HENNINK, W. E. Pharmaceutical Research, 2000, 17, 690–695.
  • Core-shell functional nanospheres for oligonucleotide delivery. III. Stealth nanospheres. SPARNACCI, K., TONDELLI, L., and LAUS, M. Journal of Polymer Science Part A—Polymer Chemistry, 2000, 15, 3347–3354.
  • Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. LYASS, 0., UZIELY, B., BEN-YOSEF, R., TZEMACH, D., HESHING, N. I., LOTEM, M., BRUFMAN, G., and GABIZON, A. Cancer, 2000, 1, 1037–1047.
  • Craft copolymers having hydrophobic backbone and hydrophilic branches. XXX. Preparation of polystyrene-core nanospheres having a poly(2-methacryloyloxyethyl phosphoryl-choline) corona. UCHIDA, T., FURUZONO, T., ISHIHARA, K., NAKABAYASHI, N., and AKASHI, M. Journal of Polymer Science Part A—Polymer Chemistry, 2000, 1, 3052–3058.
  • Curdlan gels as protein drug delivery vehicles. Kim, B. S., JUNG, I. D., Kim, J. S., LEE, J., LEE, I. Y., and LEE, K. B. Biotechnology Letters, 2000, 22, 1127–1130.
  • Cytokine-induced functional suppression of microencapsulated rat pancreatic islets in vitro. KING, A., ANDERSSON, A., and SANDLER, S. Transplantation, 2000, 70, 380–383.
  • Cytomimetic modeling in which one phospholipid liposome chemically attacks another. MENGER, F. M., and Azov, V. A. Journal of the American Chemical Society, 2000, 122, 6492–6493.
  • Design of fusogenic liposomes using a poly(ethylene glycol) derivative having amino groups. KONO, K., IwAmoTo, M., NISHEKAWA, R., YANAGIE, H., and TAKAGISHE, T. Journal of Controlled Release, 2000, 68, 225–235.
  • Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in lipo-somes for the physicochemical characterization of stealth liposomes. SHEMADA, K., MATSUO, S., SADZUKA, Y., MIYAGISHIMA, A., NOZAWA, Y., HIROTA, S., and SONOBE, T. International Journal of Pharmaceutics, 2000, 203, 255–263.
  • Development of magnetic microbubbles for drug delivery system (DDS). SOETANTO, K., and WATARAI, H. Japanese Journal of Applied Physics Part 1—Regular Papers, Short Notes Review Papers, 2000, 39, 3230–3232.
  • DNA vaccines: a role for liposomes. GREGORIADI G. Current Opinion in Molecular Therapeutics, 1999, 1, 39–42.
  • Effect of cholesterol on molecular transport of organic cations across liposome bilayers probed by second harmonic generation. YAN, E. C. Y., and EISENTHAL, K. B. Biophysical Journal, 2000, 79, 898–903.
  • Effect of immersion in SBF on porous bioactive bodies made by sintering bioactive glass microspheres. YLANEN, H., KARLSSON, K. H., ITALA, A., and ARO, H. T. Journal of Non-Crystalline Solids, 2000, 275, 107–115.
  • Effect of leucinyl-phenylalanyl-valine on DMPC liposome membrane. SHOBINI, J., and MISHRA, A. K. Spectrochimica Acta Part A—Molecular and Biomolecular Spectroscopy, 2000, 56, 2239–2248.
  • Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Cm, S. W., SONG, S. H., and Cum, Y. W. Archives of Pharmacal Research, 2000, 23, 385–390.
  • Efficacy of agarose/polystyrene sulfonic acid microencapsulation for islet xenotransplanta-tion. AOMATSU, Y., NAKAJIMA, Y., OHYAMA, T., KIN, T., KANEHIRO, H., HISANAGA, M., Ko, S., NAGAO, M., TATEKAWA, Y., SHO, M., IKEDA, N., KANOKOGI, H., KOBAYASHI, T., URIZONO, Y., YAMADA, T., SHIBAJI, T., KANAMURA, T., OGAWA, S., IWATA, H., and NAKANO, H. Transplantation Proceedings, 2000, 32, 1071–1072.
  • End-capped associative polymer chains between nanospheres: attractions in ideal solutions. BHATIA, S. R., and RUSSEL, W. B. Macromolecules, 2000, 33, 5713–5720.
  • Evaluation of liposome-water partitioning of organic acids and bases. 2. Comparison of experimental determination methods. ESCHER, B. I., SCHWARZENBACH, R. P., and WESTALL, J. C. Environmental Science Technology, 2000, 15, 3962–3968.
  • Formation of glass microspheres with rotating electrical arc. BICA, I. Materials Science and Engineering B—Solid State Materials for Advanced Technology, 2000, 77, 210–212.
  • Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with carbamazepine. MONEGHINI, M., VOINOVICH, D., PRINCIVALLE, F., and MAGAROTTO, L. Pharmaceutical Development and Technology, 2000, 3GA, 347–353.
  • GPI-linked proteins do not transfer spontaneously from erythrocytes to liposomes. New aspects of reorganization of the cell membrane. Suzum, K., and OKUMURA, Y. Biochemistry, 2000, 39, 9477–9485.
  • Growth inhibition of human leukemia HL-60 cells by an antisense phosphodiester oligonu-cleotide encapsulated into fusogenic liposomes. KONDOH, M., MATsuYAmA, T., Suzuxi, R., MIZUGUCIK, H., NAKANISHI, T., NAKAGAWA, S., TSUTSUMI, Y., NAKANISIK, M., SATO, M., and MAYUMI, T. Biological Pharmaceutical Bulletin, 2000, 23, 1011–1013.
  • Hemodynamic effects of 15-mu m-diameter microspheres on the rat pulmonary circulation. GLENNY, R. W., BERNARD, S. L., and LAMM, W. J. Journal of Applied Physiology, 2000, 89, 499–504.
  • High-performance liquid chromatographic determination of amphotericin B in a liposomal pharmaceutical product and validation of the assay. ELDEM, T., and ARICAN-CELLAT, N. Journal of Chromatographic Science, 2000, 38, 338–344.
  • HTGR nuclear fuel based on plutonium oxide microspheres. CHERNIKOV, A. S., PERMYAKOV, L. N., KURBAKOV, S. D., CHERICASOV, A. S., DEGALTSEV, Y. G., LYSHOV, L. L., and MAKAROV, V. M. Atomic Energy, 2000, 88, 30–34.
  • Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Cm', S. H., and PARK, T. G. International Journal of Pharmaceutics, 2000, 203, 193–202.
  • Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. MATTEUCCI, M. L., ANYARAMBHATLA, G., ROSNER, G., AZUMA, C., FISHER, P. E., DEWHIRST, M. W., NEEDHAM, D., and THRALL, D. E. Clinical Cancer Research, 2000, 6, 3748–3755.
  • Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. MITTAL, S. K., AGGARWAL, N., SAILAJA, G., VAN OLPHEN, A., HOGENESCH, H., NORTH, A., HAYS, J., and MOFFATT, S. Vaccine, 2000, 15, 253–263.
  • Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice. DE OLIVEIRA, M. C., BOUTET, V., FATTAL, E., BOQUET, D., GROGNET, J. M., COUVREUR, P., and DEVERRE, J. R. Life Sciences, 2000, 67, 1625–1637.
  • In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. EGILMEZ, N. K., JoNG, Y. S., SABEL, M. S., JACOB, J. S., MATIllowiTz, E., and BANKERT, R. B. Cancer Research, 2000, 60, 3832–3837.
  • In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens. QUINDOS, G., CARRILLO-MUNOZ, A. J., RUESGA, M. T., ALONSO-VARGAS, R., MIRANDA, Y., Tun-Tun, C., RUBIO, M., WALLACE, T. L., Cossum, P. A., MARTIN-MAZUELOS, E., CISTERNA, R., and PoNroN, J. European Journal of Clinical Microbiology Infectious Diseases, 2000, 19, 645–648.
  • In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E-coli DH5 cells. PRAKASH, S., and CHANG, T. M. S. International Journal of Artificial Organs, 2000, 23, 429–435.
  • In vitro degradation and release profiles of poly-DL-lactide-poly(ethylene glycol) micro-spheres with entrapped proteins. LI, X. H., DENG, X. M., YUAN, M. L., XIONG, C. D., HUANG, Z. T., ZHANG, Y. H., and JIA, W. X. journal of Applied Polymer Science, 2000, 78, 140–148.
  • In vitro/in vivo characterization of bovine serum albumin microspheres containing dex-amethasone sodium phosphate. EROGLU, H., KAS, H. S., ONER, L., TunicoGuu, 0. F., AKALAN, N., SARGON, M. F., OZER, N., and HINCAL, A. A. STP Pharma Sciences, 2000, 10, 303–308.
  • In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity. LUDEWIG, B., BARCHIESI, F., PERICIN, M., ZINKERNAGEL, R. M., HENGARTNER, H., and SCHWENDENER, R. A. Vaccine, 2000, 19, 23–32.
  • Increased carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam): an experimental study in liver tumor-bearing rabbits. POHLEN, U., BERGER, G., BINNENHEI, M., RFSZKA, R., and BUHR, H. J. Journal of Surgical Research, 2000, 92, 165–170.
  • Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes. AFRIN, F., AN, K., and ALI, N. Journal of Parasitology, 2000, 86, 730–735.
  • Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes. VAN RENSEN, A. J. M. L., TAMS, L. S., GROSFELD-STULEMEYER, M. C., VAN EDEN, W., CROMMELIN, D. J. A., and WAUBEN, M. H. M. Pharmaceutical Research, 2000, 17, 720–726.
  • Influence of cholesterol on liposome fluidity by EPR—Relationship with percutaneous absorption. CODERCH, L., FONOLIOSA, J., ESTELRICH, J., DE LA MAZA, A., and PARR, J. L. Journal of Controlled Release, 2000, 68, 85–95.
  • Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. GAUTIER, H., CAILLON, J., LE RAY, A. M., DACULSI, G., and MERLE, C. Journal of Biomedical Materials Research, 2000, 52, 308–314.
  • Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. Li, X. H., ZHANG, Y. H., YAN, R. H., JIA, W. X., YUAN, M. L., DENG, X. M., and HUG, Z. T. Journal of Controlled Release, 2000, 68, 41–52.
  • Influence of the level of cholesteryl sulfate in the solubilization of stratum corneum lipid liposomes by sodium dodecyl sulfate. COCERA, M., LOPEZ, 0., CODERCH, L., PARRA, J. L., and DE LA MAZA, A. Colloid and Polymer Science, 2000, 278, 794–799.
  • Influence of tumour size on uptake of In-111-DTPA-labelled pegylated liposomes in a human tumour xenograft model. HARRINGTON, K. J., ROWLINSON-BUSZA, G., SYRIGOS, K. N., ABA, R. M., USTER, P. S., PETERS, A. M., and STEWART, J. S. W. British Journal of Cancer, 2000, 83, 684–688.
  • Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. EMERICH, D. F., WINN, S. R., Hu, Y. H., MARSH, J., SNODGRASS, P., LAFRENIERE, D., WrENs, T., HASLER, B. P., and BARTUS, R. T. Pharmaceutical Research, 2000, 17, 767–775.
  • Interactions between liposomes and hydroxypropylmethylcellulose. DE RUBALCAVA, C. G., RODRIGUEZ, J. L., DURO, R., ALVAREZ-LORENZO, C., CONCHEIRO, A., and SEIJO, B. International Journal of Pharmaceutics, 2000, 203, 99–108.
  • Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination. SADZUKA, Y., HIROTA, S., and SONOBE, T. Toxicology Letters, 2000, 116, 51–59.
  • Intraperitoneal transplantation of microencapsulated xenogeneic hepatocytes in totally hepatectomized rats. Aux', K., HAKAMADA, K., UMEHARA, Y., SEINO, K., ITABASIE, Y., and SASAKI, M. Transplantation Proceedings, 2000, 32, 1118–1120.
  • Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. PEAN, J. M., MENEI, P., MOREL, 0., MONTERO-MENEI, C. N., and BENOIT, J. P. Biomaterials, 2000, 21, 2097–2101.
  • Lectin-mediated bioadhesion: preparation, stability and Caco-2 binding of wheat germ agglutinin-functionalized poly(D,L-lactic-co-glycolic acid)-microspheres. ERTL, B., HEIGL, F., WIRTH, M. GABOR, F. Journal of Drug Targeting, 2000, 3GA, 173.
  • Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. FAN, J., SHEK, P. N., SUNTRES, Z. E., Li, Y. H., OREOPOULOS, G. D., and ROTSTEIN, 0. D. Surgery, 2000, 128, 332–338.
  • Liposomal formulations of anticancer drugs: selectivity and effectiveness. MASSING, U., and Fuxrus, S. Drug Resistance Updates, 2000, 3GA, 171–177.
  • Liposome-assisted selective polycondensation of alpha-amino acids and peptides: the case of charged liposomes. BLOCHER, M., Lru, D. J., and Luis', P. L. Macromolecules, 2000, 33, 5787–5796.
  • Liposome-encapsulated antibiotics: physicochemical and antibacterial properties, a review. GURSOY, A. STP Pharma Sciences, 2000, 10, 285–291.
  • Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation. NORMAN, J., DENHAM, W., DENHAM, D., YANG, J., CARTER, G., ABOUHANFZE, A., TANNAHILL, C. L., MACKAY, S. L. D., and MOLDAWER, L. L. Gene Therapy, 2000, 7, 1425–1430.
  • Liposomes as carriers for DNA-PNA hybrids. NASTRUZZI, C., CORTES', R., ESPOSITO, E., GAMBARI, R., BORGATTI, M., BIANCHI, N., FERIOTTO, G., and MISCHIATI, C. Journal of Controlled Release, 2000, 68, 237–249.
  • Liposomes as carriers in electrokinetic capillary chromatography. WIEDMER, S. K., HOLOPAINEN, J. M., MUSTAKANGAS, P., KINNUNEN, P. K. J., and RIEKKOLA, M. L. Electrophoresis, 2000, 21, 3191–3198.
  • Liposomes: conquering the nuclear barrier. BRISSON, M., and HUANG, L. Current Opinion in Molecular Therapeutics, 1999, 1, 140–146.
  • Liposomes in breast-milk. KELLER, B. C., FAULKNER, G., and LASIC, D. D. Agro Food Industry Hi-Tech, 2000, 11, 6–8.
  • Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance ima-ging of the blood pool. WEISSIG, V., BABICH, J., and TORCHILIN, V. Colloids and Surfaces B—Biointerfaces, 2000, 18, 293–299.
  • Mechanism of selective release of membrane proteins from human erythrocytes in the presence of liposomes. Suzum, K., and OKUMURA, Y. Archives of Biochemistry and Biophysics, 2000, 379, 344–352.
  • Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids. GUTSMANN, T., Fix, M., LARRICK, J. W., and WIESE, A. Journal of Membrane Biology, 2000, 176, 223–236.
  • Microcapsulated parathyroid tissue in vitro. KOBAYASHI, S., AMANO, J., MINORU, F., KAzinrixo, A., SHINGU, K., Pron, K., HAMA, Y., TAKEMOTO, M., IWASAKI, T., TERAMOTO, A., and ABE, K. Biomedicine Pharmacotherapy, 2000, 54SU, 1GA, 66S.
  • Microcirculation of a venous flap: an experimental study with microspheres in rabbits. TANG, Y. B., SIMCHON, S., and CHEN, H. C. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 2000, 34, 207–212.
  • Microencapsulation of fish oil by freeze-drying techniques and influence of process par-ameters on oxidative stability during storage. HEINZELMANN, K., FRANKE, K., VELASCO, J., and MARQUEZ-RUIZ, G. European Food Research and Technology, 2000, 4GA, 234–239.
  • Microencapsulation of islets with durable polylysine-alginate membrane. KENDALL, W. F., DARRABIE, M., FREEMAN, B. K., HOBBS, H. A., Com_ms, B. H., and OPARA, E. C. Diabetes, 2000, 458, 1.
  • Microencapsulation renders wastes inert. ANON. Hydrocarbon Processing, 2000, 79, 27.
  • Mixed micelle proliposomes for preparation of liposomes containing amphotericin B, in-vitro and ex-vivo studies. SARBOLOUKI, M. N., PARSAEE, S., and KOSARY, P. PDA Journal of Pharmaceutical Science and Technology, 2000, 54, 240–246.
  • Modeling of the permeate flux during microfiltration of BSA-adsorbed microspheres in a stirred cell. CHoi, S. W., YOON, J. Y., HAAN', S., JUNG, J. K., Kim, J. H., and Kim, W. S. journal of Colloid and Interface Science, 2000, 228, 270–278.
  • Morphology of and release behavior from porous polyurethane microspheres. JABBARI, E., and KHAKPOUR, M. Biomaterials, 2000, 21, 2073–2079.
  • New bioactive, degradable composite microspheres as tissue engineering substrates. Qru, Q. Q., DUCHEYNE, P., and AYYASWAMY, P. S. Journal of Biomedical Materials Research, 2000, 52, 66–76.
  • Novel method of greatly enhanced delivery of liposomes to lymph nodes. PHILLIPS, W. T., KLIPPER, R., and GOINS, B. Journal of Pharmacology and Experimental Therapeutics, 2000, 295, 309–313.
  • Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria. FURNERI, P. M., FRESTA, M., PUGLISi, G., and TEMPERA, G. Antimicrobial Agents and Chemotherapy, 2000, 44, 2458–2464.
  • Optical characterization of liposomes by right angle light scattering and turbidity meas-urement. MATSUZAKI, K., MURASE, 0., SUGISHITA, K., YONEYAMA, S., AKADA, K., UEHA, M., NAKAMURA, A., and KOBAYASHI, S. Biochimica et Biophysica Acta—Biomembranes, 2000, 1467, 219–226.
  • Oxidative refolding of lysozyme assisted by negatively charged liposomes: relationship with lysozyme-mediated fusion of liposomes. KUBOI, R., MAWATARI, T., and Yosurmaro, M. Journal of Bioscience and Bioengineering, 2000, 90, 14–19.
  • p67-phox-mediated NADPH oxidase assembly: imaging of cytochrome b(558) liposomes by atomic force microscopy. PACLET, M. H., COLEMAN, A. W., VERGNAUD, S., and MOREL, F. Biochemistry, 2000, 39, 9302–9310.
  • Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2). SAFRA, T., MUGGIA, F., JEFFERS, S., TSA0-WEI, D. D., GROSHEN, S., LYASS, 0., HENDERSON, R., BERRY, G., and GABIZON, A. Annals of Oncology, 2000, 11, 1029–1033.
  • Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum. MARKMAN, M., KENNEDY, A., WEBSTER, K., PETERSON, G., KULP, B., and BELINSON, J. Gynecologic Oncology, 2000, 78, 369–372.
  • Phase II study of liposomal doxorubicin in advanced gynecologic cancers. ISRAEL, V. P., GARCIA, A. A., ROMAN, L., MUDERSPACH, L., BURNETT, A., JEFFER.s, S., and MUGGIA, F. M. Gynecologic Oncology, 2000, 78, 143–147.
  • Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer. GORDON, A. N., GRANAI, C. 0., ROSE, P. G., HAINSWORTH, J., LOPEZ, A., WEISSMAN, C., ROSALES, R., and SHARPINGTON, T. Journal of Clinical Oncology, 2000, 18, 3093–3100.
  • Plain and drug loaded polyphosphazene membranes and microspheres in the treatment of rabbit bone defects. PASSI, P., ZADRO, A., MARSILIO, F., LORA, S., CALICETI, P., and VERONESE, F. M. Journal of Materials Science—Materials in Medicine, 2000, 11, 643–654.
  • Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. LAMBERT, G., FATTAL, E., PINTO-ALPHANDARY, H., Gur.ix, A., and COUVREUR, P. Pharmaceutical Research, 2000, 17, 707–714.
  • Polymer and microsphere blending to alter the release of a peptide from PLGA micro-spheres. RAVIVARAPU, H. B., BURTON, K., and DELmA, P. P. European Journal of Pharmaceutics and Biopharmaceutics, 2000, 50, 263–270.
  • Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circula-tion and RES uptake in rats. TAKEUCHI, H., Koji, H., YAMAMOTO, H., and KAWASHIMA, Y. Journal of Controlled Release, 2000, 68, 195–205.
  • Polymer metal composite microspheres-Preparation and characterization of poly(St-co-AN)Ni microspheres. WANG, P. H., and PAN, C. Y. European Polymer Journal, 2000, 36, 2297–2300.
  • Polysaccharide coated liposomes for oral immunization-development and characteriza-tion. VENKATESAN, N., and VYAS, S. P. International Journal of Pharmaceutics, 2000, 203, 169–177.
  • Polyurea microcapsules with different structures: preparation and properties. HONG, K., and PARK, S. Journal of Applied Polymer Science, 2000, 78, 894–898.
  • Preparation and properties of immobilized amyloglucosidase on nonporous PS/PNaSS microspheres. OH, J. T., and KIM, J. H. Enzyme and Microbial Technology, 2000, 27, 356–361.
  • Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. WATNASIRICHAIKUK S., DAVIES, N. M., RADES, T., and TUCKER, I. G. Pharmaceutical Research, 2000, 17, 684–689.
  • Prevention of the hemodynamic effects of iopromide-carrying liposomes in rats and pigs. KRAUSE, W., GERLACH, S., and MusonHx, P. Investigative Radiology, 2000, 35, 493–503.
  • Preventive effect of vitamin E-containing liposome instillation on cataract progression in 12-month-old rats fed a 25% galactose diet. OHTA, Y., YAMASAKI, T., NIWA, T., and MAHmA, Y. Journal of Ocular Pharmacology and Therapeutics, 2000, 16, 323–335.
  • Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres. O'BRIEN, C. N., GUIDRY, A. J., FATTOM, A., SHEPHERD, S., DOUGLASS, L. W., and WESTHOFF, D. C. Journal of Dairy Science, 2000, 83, 1758–1766.
  • Progesterone release from glutaraldehyde cross-linked casein microspheres: In vitro studies and in vivo response in rabbits. LATHA, M. S., LAL, A. V., KUMARY, T. V., SREEKUMAR, R., and JAYAKRISHNAN A. Contraception, 2000, 61, 329–334.
  • Protection of fish oil from oxidation by microencapsulation using freeze-drying techniques. HEINZELMANN, K., FRANKE, K., JENSEN, P., and HAAHR, A. M. European Journal of Lipid Science and Technology, 2000, 102, 114–121.
  • Radiolabelled biodegradable microspheres for lung imaging. DELGADO, A., SORIANO, I., SANCHEZ, E., OLIVA, M., and EVORA, C. European Journal of Pharmaceutics and Biopharmaceutics, 2000, 50, 227–236.
  • Selective gene expression in hepatic tumor with trans-arterial delivery of DNA/liposome/ transferrin complex. SEOL, J. G., HEO, D. S., Km, H. K., YOON, J. H., CHHI, B. I., LEE, H. S., KIM, N. K., and KIM, C. Y. In Vivo, 2000, 14, 513–517.
  • Selective uptake by cancer cells of liposomes coated with polysaccharides bearing 1-aminolactose. MATSUKAWA, S., YAMAMOTO, M., ICIKNOSE, K., OHATA, N., Ism, N., KOHJI, T., AKIYOSHI, K., SUNAMOTO, J., and KANEMATSU, T. Anticancer Research, 2000, 20, 2339-2344. Simultaneous measurement of thyroxine and thyrotropin from newborn dried blood-spot specimens using a multiplexed fluorescent microsphere immunoassay. BELLISARIO, R., COLINAS, R. J., and PASS, K. A. Clinical Chemistry, 2000, 46, 1422–1424.
  • Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. EL MAGHRABY, G. M. M., WILLIAMS, A. C., and BARRY, B. W. International Journal of Pharmaceutics, 2000, 204, 159–169.
  • Specific interaction of cytosolic and mitochondrial glyoxalase II with acidic phospholipids in form of liposomes results in the inhibition of the cytosolic enzyme only. SCIRE, A., TANFANI, F., SACCUCCI, F., BERTOLI, E., and PRINCIPATO, G. Proteins-Structure Function and Genetics, 2000, 41, 33–39.
  • Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres. MARININA, J., SHENDEROVA, A., MALLERY, S. R., and SCHWENDEMAN, S. P. Pharmaceutical Research, 2000, 17, 677–683.
  • Studies on the structure and controlled release of chitosan/fibroin microsphere inclusion drug. PENG, X. H., ZHANG, L. N., and PAN, X. L. Acta Polymerica Sinica, 2000, 4GA, 348TTJ9, 502–505.
  • Successful treatment of bilateral renal fungal balls with liposomal amphotericin B and fluconazole in an extremely low birth weight infant. STOCKER, M., CADUFF, J. H., SPALINGER, J., and BERGER, T. M. European Journal of Pediatrics, 2000, 159, 676–678.
  • Superficially porous silica microspheres for fast high-performance liquid chromatography of macromolecules. KIRKLAND, J. J., TRUSZKOMSKI, F. A., Dnxs, C. H., and ENGEL, G. S. Journal of Chromatography A, 2000, 890, 3–13.
  • Targeted delivery of prostaglandin E-1 to hepatocytes using galactosylated liposomes. KAWAKAMI, S., MUNAKATA, C., FUMOTO, S., YAMASHITA, F., and HASIKDA, M. Journal of Drug Targeting, 2000, 3GA, 137–142.
  • The effects of intrathecal morphine encapsulated in L- and D-dipalmitoylphosphatidyl choline liposomes on acute nociception in rats. Nrson(AmA, T., Ho, R. J. Y., SHEN, D. D., and YAKSH, T. L. Anesthesia and Analgesia, 2000, 91, 423–428.
  • The properties of amylose-ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. SIEW, L. F., BAS IT, A. W., and NEwroN, J. M. European Journal of Pharmaceutical Sciences, 2000, 11, 133–139.
  • The use of magnetite-doped polymeric microspheres in calibrating cell tracking veloci-naetry. MOORE, L. R., ZBOROWSKI, M., NAKAMURA, M., MCCLOSKEY, K., GURA, S., ZUBERI, M., MARGEL, S., and CHALMERS, J. J. Journal of Biochemical and Biophysical Methods, 2000, 44, 115–130.
  • Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. GASPAR, M. M., NEVES, S., PORTAELS, F., PEDROSA, J., SILVA, M. T., and CRUZ, M. E. M. Antimicrobial Agents and Chemotherapy, 2000, 44, 2424–2430.
  • Transcranial doppler flow velocity vs. cerebral blood flow in pigs—A validation study using the radioactive microspheres method. SCHMIDT, M., PAPP-JAMBOR, C., SCHIRMER, U., KOTZERKE, J., TOPALIDIS, P., MARX, T., and REINELT, H. ACP—Applied Cardiopulmonary Pathophysiology, 2000, 2GA, 97–102.
  • Triblock nanospheres and their use as templates for inorganic nanoparticle preparation. UNDERHILL, R. S., and Lru, G. J. Chemistry of Materials, 2000, 12, 2082–2091.
  • Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. HAFEZ, I. M., ANSELL, S., and Cia.m.s, P. R. Biophysical Journal, 2000, 79, 1438–1446.
  • Use of floating alginate gel beads for stomach-specific drug delivery. MURATA, Y., SASAKI, N., MIYAMOTO, E., and KAWASHIMA, S. European Journal of Pharmaceutics and Biopharmaceutics, 2000, 50, 221–226.
  • Use of spray-dried zirconia microspheres in the separation of immunoglobulins from cell culture supernatant. SUBRAMANIAN, A., CARR, P. W., and MCNEFF, C. V. Journal of Chromatography A, 2000, 890, 15–23.
  • Viability of microencapsulated bifidobacteria in set yogurt during refrigerated storage. ADHIKARI, K., MUSTAPHA, A., GRUN, I. U., and FERNANDO, L. Journal of Dairy Science, 2000, 83, 1946-1951.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.